Excessive fluid loss and decreased blood volume following a severe burn may lead to:

A. Hypercapnia is correct because it refers to an abnormally high level of carbon dioxide (CO₂) in the blood, often resulting from hypoventilation, respiratory diseases (like COPD), or impaired gas exchange. Elevated CO₂ can lead to respiratory acidosis, causing confusion, headache, lethargy, and, in severe cases, respiratory failure.

B. Hypocapnia is incorrect because this term refers to abnormally low CO₂ levels in the blood, which can occur due to hyperventilation. Hypocapnia can lead to respiratory alkalosis with symptoms such as dizziness, tingling, and muscle cramps.

C. Hypoxemia is incorrect because hypoxemia refers to low oxygen levels in the blood, not elevated carbon dioxide. It may result from lung disease, high altitude, or impaired oxygen transport.

D. Hyperpnea is incorrect because hyperpnea refers to increased depth and rate of breathing, usually as a compensatory mechanism for increased CO₂ or metabolic demands, rather than the presence of elevated CO₂ itself.

A. Lung damage caused by COPD is reversible is incorrect because COPD involves chronic, progressive destruction of the airways and alveoli, particularly in emphysema and chronic bronchitis. While medications and interventions can manage symptoms and slow progression, the structural lung damage is irreversible.

B. COPD refers only to chronic bronchitis is incorrect because COPD is a broad term that encompasses multiple chronic lung conditions, primarily chronic bronchitis and emphysema. Some patients may have features of both, and less commonly, COPD can be influenced by alpha-1 antitrypsin deficiency.

C. COPD affects only those of European descent is incorrect because COPD affects individuals worldwide regardless of ethnicity. While certain genetic factors (e.g., alpha-1 antitrypsin deficiency) are more prevalent in some populations, the disease is not limited to European descent.

D. Smoking is the primary cause of COPD is correct because long-term cigarette smoking is the leading risk factor. Tobacco smoke causes chronic airway inflammation, mucus hypersecretion, ciliary dysfunction, and destruction of alveolar walls, leading to airflow limitation, impaired gas exchange, and progressive respiratory symptoms. Other contributing factors include environmental exposures (pollution, occupational dust), recurrent respiratory infections, and genetic susceptibility.